Skip to main content

Table 3 Baseline characteristics of the patients

From: Comparison of intraoperative handling and wound healing between (NEOSORB® plus) and coated polyglactin 910 suture (NEOSORB®): a prospective, single-blind, randomized controlled trial

 

NEOSORB Plus (n = 47)

NEOSORB (n = 49)

p

Age (years)

59.6 ± 12.16

56.16 ± 14.00

0.21

Gender

  

0.50

 Men

35 (74.5%)

35 (71.4%)

 

 Women

12 (25.5%)

14 (28.6%)

 

History of other disease

 HTN

15 (34.5%)

13 (23.4%)

0.32

 DM

6 (16.7%)

10 (20.4%)

0.36

 Vascular Disease

3 (6.4%)

0 (0%)

0.12

Target organ for surgery

  

0.53

 Kidney

26 (55.3%)

26 (53.1%)

 

 Bladder

2 (4.2%)

4 (8.2%)

 

 Prostate

16 (34.0%)

15 (30.6%)

 

 Other

3 (6.4%)

4 (8.2%)

 

Length of incision (cm)

13.30 ± 4.49

14.75 ± 3.90

0.55

  1. HTN hypertension, DM diabetes mellitus